Brain Biotech AG logo

Brain Biotech AG (BNN)

Market Open
15 Aug, 20:00
2. 01
-0.03
-1.47%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
2.04
Previous Close
Day Range
1.96 2.01
Year Range
1.41 4.39
Want to track BNN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 10 days

Summary

BNN trading today lower at €2.01, a decrease of 1.47% from yesterday's close, completing a monthly decrease of -6.51% or €0.14. Over the past 12 months, BNN stock lost -44.78%.
BNN is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 28, 2025.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on XETRA (EUR).

BNN Chart

Brain Biotech AG (BNN) FAQ

What is the stock price today?

The current price is €2.01.

On which exchange is it traded?

Brain Biotech AG is listed on XETRA.

What is its stock symbol?

The ticker symbol is BNN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Aug 28, 2025.

Has Brain Biotech AG ever had a stock split?

No, there has never been a stock split.

Brain Biotech AG Profile

Specialty Chemicals Industry
Basic Materials Sector
Mr. Adriaan Moelker CEO
XSTU Exchange
DE0005203947 ISIN
Germany Country
319 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

BRAIN Biotech AG is a leading company in the field of biotechnological research and development, primarily focusing on creating bio-based products and solutions. The company operates from its headquarters in Zwingenberg, Germany, and extends its operations across several countries including Germany, the United States, France, the Netherlands, and the United Kingdom. Its business activities are segmented into three main divisions: BioProducts, BioScience, and BioIncubator, each targeting specific areas of biotechnological application and development. Originally known as B.R.A.I.N. Biotechnology Research and Information Network AG, the company underwent a name change to BRAIN Biotech AG in April 2021, reflecting its evolving focus and expansion into various biotech applications. Founded in 1993, BRAIN Biotech AG has been at the forefront of leveraging biotechnology to address environmental challenges, optimize industrial production processes, and innovate in the production of food, beverages, and healthcare products.

Products and Services

  • Enzymes and Biocatalysts:

    BRAIN Biotech AG develops enzymes and biocatalysts tailored for various industries, including food and beverage production, healthcare, and industrial lubricants. These include solutions for wound care preparations, the production of starch, and bioethanol. The company's biocatalysts improve efficiency and sustainability in manufacturing processes, reducing environmental impact while enhancing product quality.

  • Microorganisms:

    The company harnesses the power of microorganisms to serve as functional biomass. These innovative solutions are aimed at optimizing industrial production processes, recycling greenhouse gases like CO2 for use as industrial raw materials, and facilitating urban and green mining to extract precious and rare earth metals efficiently.

  • Biocatalysts for Food, Cosmetics, and Medical Products:

    BRAIN Biotech AG provides biocatalysts and bioactive natural compounds for the production of foodstuffs, animal feed, cosmetics, and medical products, catering to the needs of chemical companies, waste and hazardous materials disposal, energy, and raw materials production sectors. These bio-based solutions aim to enhance product safety, sustainability, and performance across various applications.

Contact Information

Address: DarmstAedter Strasse 34-36
Phone: 49 62 51 9331 0